Companies

30/31
Image
Image
Evasive founders
fund II
Industrial tech

Evasive Robotics

EVASIVE Robotics enables robots to work together seamlessly in complex industrial environments.

More about Evasive Robotics
Image
Image
Aperio founders
fund II
Life Science

Aperio Therapeutics

Aperio Therapeutics is developing an innovative biological treatment for diseases related to metabolic physiology

More about Aperio Therapeutics
Image
Image
the collimatehealth team posing in front of banister wearing team shirts
fund II
Life Science

Collimate Health

Collimate Health is developing a new generation of radiotherapy technology aimed at improving how cancer is treated

More about Collimate Health
Image
Image
PureSurf
fund II
Life Science

PureSurf

PureSurf is an Austrian deep-tech company developing sustainable specialty chemicals from renewable resources

More about PureSurf
Image
Image
team of Invisible Light Labs
fund II
Industrial tech

Invisible Light Labs

Invisible-Light Labs (ILL) is a deep-tech company spun out of TU Wien that is redefining how scientists and industrial users analyze and understand extremely small quantities of material

More about Invisible Light Labs
Image
Image
Epitome Team
fund II
Life Science

Epitome Therapeutics

Epitome Therapeutics is developing a new generation of programmable genetic medicines designed to address diseases caused by incorrect gene expression.  

More about Epitome Therapeutics
Image
Image
the two founders Julia Reisinger and Maria Zahlbruckner in front of a factory
fund II
Industrial tech

factorymaker

Industrial buildings and data centers define competitiveness, resilience, and energy demand. Yet their early stage planning remains fragmented and constrained, even as complexity continues to rise. factorymaker transforms this decisive phase into a computational process. By enabling systematic exploration and optimisation of design alternatives, the platform allows efficiency, flexibility, and sustainability to be embedded from the start. We believe factorymaker is building a foundational layer for how complex industrial systems will be conceived and realised in the future.

More about factorymaker
Image
Image
picture of multi-coloured structure spanning a net over a black background
fund II
Life Science

Amplifold

Amplifold elevates rapid diagnostics to a new performance level. By integrating DNA origami nanostructures into conventional lateral flow tests, the company increases sensitivity by up to one hundred fold without requiring instruments or changes to manufacturing. This enables laboratory-level performance in a familiar strip-based format, opening new possibilities in infectious disease, oncology and decentralised testing.

More about Amplifold
Image
Image
screenshot of aves application showing a drone picture of a city next to a map
fund II
Industrial tech

AVES reality

Autonomous cars are among the most complex physical AI systems ever built. They must operate safely in open, dynamic environments, yet validating them in the real world remains slow, expensive, and fundamentally limited.
AVES Reality addresses this bottleneck by building a foundational infrastructure layer for autonomous driving: accurate, simulation-ready 3D digital twins of the real world, generated automatically at global scale.
Using satellite and aerial imagery combined with geospatial AI, advanced computer graphics, and physics-aware modeling, AVES Reality reconstructs cities, road

More about AVES reality
Image
Image
Ora Founders Stefan Sack and Raimel A. Medina
fund II
Industrial tech

Ora Computing

Ora Computing is an AI deployment company specializing in optimizing and compressing Artificial Intelligence (AI) foundation models. They develop AI techniques that automate manual labor mostly on edge devices, such that small and performant models can be deployed on phones, laptops, IoT devices, and cars.

More about Ora Computing
Image
Image
Syntropic medical goggles
fund I
Life Science
on site

Syntropic Medical

Syntropic develops a non-invasive and non-pharmaceutical treatment for mental health disorders. Through light stimulation, neural remodeling is activated by instructing the immune cells of the brain to support in healing and recovery.

More about Syntropic Medical
Image
Image
pink pipette over a case with various vials
fund I
Life Science

HEPHAISTOS Pharma

ONCO-Boost, the first product from HEPHAISTOS-Pharma’s platform, is a natural TLR4 agonist that stimulates the patients’ own immune system to strengthen both innate and adaptive immune systems to strengthen their responses against cold tumors.

More about HEPHAISTOS Pharma
Image
Image
the two founders in the lab wearing lab coats and safety glasses
fund I
Industrial tech

Rivus Batteries


Batteries are needed to store renewable energy – it's not always windy when you want it to be, and the same applies to the hours of sunshine. Rivus’ idea is for gigantic batteries to be placed at solar and wind farms.

More about Rivus Batteries
Image
Image
screen shot of infrared application showing the simulation of a city
fund I
Industrial tech

Infrared City

Infrared.city is a platform for intelligent and resilient architecture and construction design powered by Artificial Intelligence. Using simulation prediction models, infrared.city can deliver simulation results at a fraction of the computational time and financial cost. Their state of the art machine learning models provide real-time feedback on the performance of design proposals and can guide climate informed decisions at every step of the process.

More about Infrared City
Image
Image
the two founders in behind a subdron drone
fund I
Industrial tech

Subdron

subdron is dedicated to transforming underwater inspections through the development of close range navigation for Autonomous Underwater Vehicles (AUVs) and automatized data processing and analysis. By leveraging vanguard hardware technology and artificial intelligence, subdron aims to revolutionize the way underwater structures such as port infrastructure and ship hulls are inspected for damages and biofouling. Their mission is to provide efficient, cost-effective, and environmentally friendly solutions for underwater infrastructure management.

More about Subdron
Image
Image
recatalyst product and packaging on table in front of lab in blue light
fund I
Industrial tech

ReCatalyst

ReCatalyst reduces required platinum in fuel cell catalysts for applications in heavy duty transport, while improving efficiency and durability

More about ReCatalyst
Image
Image
red light laser of vitrealab
fund I
Industrial tech

VitreaLab

VitreaLab is commercializing integrated laser powered photonic devices that will transform displays as we know them. Inspired by quantum photonic technologies, VitreaLab developed its “Quantum Light Engine” which is a light source capable of illuminating AR, VR, and 3D displays with laser light of unprecedented brightness and perfect colour quality while consuming just a fraction of the energy needed by other technologies.

More about VitreaLab
Image
Image
wo dancers in black and white with colorful, abstract, bubble shapes
fund I
Life Science
on site

Solgate

Solgate’s founders combine deep expertise in the biology of solute carriers with unique chemistry-based approaches for accelerated drugging of difficult targets. Current projects are focused on CNS and immunology indications.

More about Solgate
Image
Image
person in industry lab setting surrounded by shelfes, boxes, cables, etc.
fund I
Life Science
Retired

Sarcura


Sarcura set out to tackle one of the toughest challenges in advanced medicine: how to manufacture cell therapies at scale. With an interdisciplinary founders team and a research-derived, innovative product for a growing market, they aimed to miniaturize and automate cell therapy production on a chip.

At xista science ventures, we are proud to have supported this journey from its early days, providing capital, infrastructure, and a place in our community. While Sarcura will not continue as a company, it's achievements and people remain part of our ecosystem as a Retired Innovation Pioneer. This

More about Sarcura
Image
Image
hand holding up a vial with label "Ribbon Biolabs"
fund I
Life Science

Ribbon Biolabs

Ribbon Biolabs is a synthetic biology leader driving DNA synthesis beyond the limits of current technologies. With their automated, enzyme-based platform, Ribbon Biolabs can provide synthetic DNA molecules without size or sequence limitations at a high level of accuracy and at unprecedented speed.

More about Ribbon Biolabs
Image
Image
screenshot of application showing a world map
fund I
Industrial tech

Prewave

Transparency and actionable insights are becoming increasingly important in an interconnected world with complex supply chains and increasing disruption risks. Finding, monitoring and analyzing disruption- and sustainability risks is a tremendous challenge for almost every industry. With its technology, prewave is making supply chains more resilient and sustainable.

More about Prewave
Image
Image
screen shot of nista application showing graphs
fund I
Retired

nista.io

Sustainable energy systems need ambitious goals, novel technologies, as well as stringent execution. nista develops an AI-powered data analysis software that they offer as an Energy Efficiency as a Service tool for the energy intensive industry.

More about nista.io
Image
Image
hands in labcoat and gloves using a pipette in a lab
fund I
Life Science

G.ST Antivirals

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against respiratory tract infections. Founded in 2019 by Guido Gualdoni and Johannes Stöckl, the company leverages an innovative host cell-based strategy to overcome respiratory viral infections. This approach is based on a high-impact paper on the interaction of a respiratory virus with the infected cell, which was published by the founders while working at the Medical University of Vienna.

More about G.ST Antivirals
Image
Image
two scientists in a lab
fund I
Life Science

Cutanos

The immune system protects our body against bacteria, viruses and other external threats to our health. Dendritic cells (DCs) play a central role by recognizing such pathogens, processing them and training other immune cells to act against them. At the same time, DCs are also responsible for tolerating the body’s own structures (autoantigens). This complex interaction is achieved by an „orchestra“ of different types of DCs. Cutanos aims to use these mechanisms to develop both vaccines and therapies against autoimmune diseases and allergies.

More about Cutanos
Image
Image
gloved hands in a lab in front of vials and measuring tool
fund I
Life Science

Cellectric

The cell is at the center of current and future biological science. Future trends require novel technologies to unlock their full potential. The combination of electrodynamics and biotechnology perfectly complements the requirements of emerging industries when it comes to efficient analysis and modulation of biological cells.

More about Cellectric
Image
Image
patient sitting in medical stool, two scientists taking notes and checking the screen
fund I
Life Science
Retired

Brightmind.AI

Brightmind.AI is developing therapeutic TMS (transcranial magnetic stimulation) devices for home use, with a first indication of migraine.

More about Brightmind.AI
Image
Image
graphic of molecules
fund I
Life Science

Valanx Biotech

By means of synthetic biology and genetic code expansion Valanx has developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. Based on this platform Valanx is developing a number of cutting-edge biologics towards potential treatments for various indications.

More about Valanx Biotech
Image
Image
person sitting in front of screen showing contextflow application
fund I
Life Science
Exited

Contextflow

Artificial Intelligence (AI) is increasingly prevalent in business and society. An area where AI is performing well already is healthcare, with significant developments in early detection, diagnostics, decision making or workflow support providing clinical value.

More about Contextflow
Image
Image
three scientists working at different stations in a lab
fund I
Life Science
on site

Neurolentech

Neurolentech is a spinoff of ISTA (Institute of Science and Technology Austria) focused on personalized medicine for neurodevelopmental disorders. The company is developing and characterizing libraries of patient-derived neuronal cells, and will leverage this unique resource for the development of novel therapeutics to tackle severe forms of autism and epilepsy.

More about Neurolentech